Portfolio company
CheckEye
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform for mass screening of diabetic retinopathy and other chronic diseases for clinics, pharmacies and health organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Macuject
This company develops artificial intelligence software that analyses macular scans to assist clinicians and pharmaceutical organisations in treating retinal diseases.
Deepeye Medical
This company develops artificial intelligence software that analyses eye scans to provide therapy planning support for ophthalmologists treating retinal diseases.
RetinaRisk
This company develops a risk assessment application and API for diabetic retinopathy, serving patients, healthcare professionals and health insurers.
Aireen
The company develops autonomous software that detects eye and chronic diseases from retinal scans for healthcare providers, optical stores, and screening programmes.
Oivi
The company develops an automated retinal camera and AI platform for primary care providers to screen patients for diabetic eye disease.
AI-Sight
This company develops artificial intelligence software for diabetic retinopathy screening to assist clinicians in diagnostic decision-making for healthcare providers.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
eye2gene
Eye2Gene develops an AI-powered platform that analyses retinal imaging to accelerate genetic diagnosis of inherited diseases for pharmaceutical companies and eye care professionals.